Home » Topics » BioWorld Science

BioWorld Science
RSS

Aeglea reports phase I/II data on pegzilarginase in patients with arginase 1 deficiency

April 16, 2018

FDA grants fast track designation to tenalisib for the treatment of relapsed/refractory CTCL

April 16, 2018

Eisai enters research agreement to develop new treatments for tuberculosis

April 16, 2018

Deinove to acquire Biovertis and clinical-stage antibiotic

April 16, 2018

FDA removes clinical hold and allows initiation of phase I/II study of MRT-5005

April 16, 2018

FDA approves use of IDx-DR to detect diabetic retinopathy

April 13, 2018

PCSK7, a potential therapeutic target for metabolic disorders

April 13, 2018

GSK to transfer rare disease gene therapy portfolio to Orchard Therapeutics

April 13, 2018

Phase I/II study of DNA vaccine for hypertension begins in Australia

April 13, 2018

FDA finalizes guidance on NGS-based tests

April 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...